‹ Back to ONESOURCE.NS

ONESOURCE.NS Profit & Loss

Onesource Specialty Pharma Ltd.

Profit & Loss Balance Sheet Cash Flow

Profit & Loss · 2 years on file (FY2024-25 to FY2025-26) · fetched 2026-08-23 23:41
Line item FY2024-25 FY2025-26 Source (XBRL element)
Revenue from Operations ₹1,444.85 Cr. ₹1,421.59 Cr. RevenueFromOperations
Gross Revenue (incl. inter-segment) N/A N/A SegmentRevenueFromOperations
Other Income ₹17.47 Cr. ₹15.02 Cr. OtherIncome
Total Income ₹1,462.33 Cr. ₹1,436.61 Cr. Income
Cost of Materials Consumed ₹328.24 Cr. ₹436.75 Cr. CostOfMaterialsConsumed
Purchases of Stock-in-Trade ₹30.10 Cr. ₹0.00 Cr. PurchasesOfStockInTrade
Changes in Inventories ₹76.69 Cr. ₹7.89 Cr. ChangesInInventoriesOfFinishedGoodsWorkInProgressAndStockInTrade
Employee Benefit Expense ₹215.26 Cr. ₹242.25 Cr. EmployeeBenefitExpense
Finance Costs ₹166.32 Cr. ₹122.19 Cr. FinanceCosts
Depreciation and Amortisation ₹273.88 Cr. ₹279.09 Cr. DepreciationDepletionAndAmortisationExpense
Other Expenses ₹328.05 Cr. ₹430.47 Cr. OtherExpenses
Total Expenses ₹1,418.55 Cr. ₹1,518.65 Cr. Expenses
Profit Before Exceptional Items and Tax ₹43.78 Cr. ₹-82.03 Cr. ProfitBeforeExceptionalItemsAndTax
Exceptional Items ₹-110.84 Cr. ₹-9.93 Cr. ExceptionalItemsBeforeTax
Profit Before Tax ₹-67.07 Cr. ₹-91.96 Cr. ProfitBeforeTax
Tax Expense ₹-49.78 Cr. ₹-18.16 Cr. TaxExpense
Net Profit (incl. minority interest) ₹-17.97 Cr. ₹-73.80 Cr. ProfitLossForPeriod
Net Profit (to shareholders) N/A ₹-73.80 Cr. ProfitOrLossAttributableToOwnersOfParent
Basic EPS ₹-1.63 ₹-6.44 BasicEarningsLossPerShareFromContinuingAndDiscontinuedOperations
Diluted EPS ₹-1.63 ₹-6.44 DilutedEarningsLossPerShareFromContinuingAndDiscontinuedOperations

Every figure above is the exact value of the named XBRL element from ONESOURCE.NS's cached filing for that year — nothing here is estimated or backfilled. A company shows one column per year StockProof actually has data for — never padded with blank years. Rows shown as N/A are genuinely not disclosed under that year's filing format (see peer comparison for how other Healthcare companies compare).